Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
42.3M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
11.4K
-
Shares change
-
+11.4K
-
Total reported value, excl. options
-
$232K
-
Value change
-
+$232K
-
Number of buys
-
1
-
Price
-
$20.25
Significant Holders of Tarsus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (TARS) as of Q4 2023
1 filings reported holding TARS - Tarsus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Tarsus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (TARS) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.4K shares
of 42.3M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.15M shares), BlackRock Inc. (2.52M shares), Cormorant Asset Management, LP (2.22M shares), TANG CAPITAL MANAGEMENT LLC (2.2M shares), MORGAN STANLEY (1.96M shares), COWEN AND COMPANY, LLC (1.91M shares), Frazier Life Sciences Management, L.P. (1.79M shares), Vivo Capital, LLC (1.78M shares), VANGUARD GROUP INC (1.6M shares), and PERCEPTIVE ADVISORS LLC (1.3M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.